TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.49, sa.1, ss.110-115, 2019 (SCI İndekslerine Giren Dergi)
Background/aim: Adropin is a peptide-structure hormone that plays a role in preventing the development of insulin resistance, which has been linked to obesity and metabolic regulation. The purpose of this study is to assess serum adropin levels and their relationship with metabolic parameters in psoriasis vulgaris patients both with and without metabolic syndrome (MetS).